Investing Profile

Roel Bulthuis

InvestorVC
Managing Director at INKEF Capital
inkefcapital.com/team/Amsterdam, Netherlands
Photo of Roel Bulthuis, Managing Director at INKEF Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
INKEF Capital Managing Director
$100K - $5.0M
$1.5M
12
€500M
CompanyStageDateRound SizeTotal Raised
iOnctura
Series BJun 2024$86M
$110M
Co-investors: Hakan Goker (M Ventures (Merck)), Keno Gutierrez (BGV (BioGeneration Ventures)), Fiona MacLaughlin (Johnson & Johnson Innovation)
QurAlis
Series BMar 2023$88M
Series AMay 2020$42M
$140M
Co-investors: Amy Schulman (Polaris Partners), Johannes Fruehauf (Mission BioCapital), Philip Scheltens (EQT Life Sciences), Cillian King (EQT Life Sciences), Jeffrey Moore (MP Healthcare Venture Management), Laia Crespo (Sanofi Ventures), Stephen Thompson (Brandon Capital Partners)
NMD Pharma
Series UnknownFeb 2022$40M
$40M
Salvia BioElectronics
Series ASep 2020$31M
$31M
VarmX
Series BJul 2020$36M
$83M
Co-investors: Hermann Hauser (Amadeus Capital Partners), John de Koning (EQT Life Sciences), Oscar Slotboom (BGV (BioGeneration Ventures))
Comet Therapeutics
Series AJun 2019$29M
$29M
Co-investors: Colleen Cuffaro (Canaan Partners), Henrijette Richter (Soffinova Partners)
aveni
Series BOct 2017$10M
$10M
Bird Rock Bio
Series BMar 2014$15M
$61M
Co-investors: Richard Ulevitch (5am Ventures), Andrew Schwab (5am Ventures), Simeon J. George (SR One)